Showing results (301-310 of 334) with videos related to

Sort By:
Pageof 34
The Lancet. Infectious Diseases|September 18, 2020
Safety, immunogenicity, and efficacy of a Clostridioides difficile toxoid vaccine candidate: a phase 3 multicentre, observer-blind, randomised, controlled trialGuy de Bruyn, David L Gordon, Theodore Steiner, et al.
Eclinicalmedicine|May 18, 2022
Immunogenicity and reactogenicity of heterologous and homologous mRNA-1273 and BNT162b2 vaccination: A multicenter non-inferiority randomized trialCécile Janssen, Marine Cachanado, Laetitia Ninove, et al.
The New England Journal of Medicine|April 20, 2022
Intramuscular AZD7442 (Tixagevimab-Cilgavimab) for Prevention of Covid-19Myron J Levin, Andrew Ustianowski, Stéphane De Wit, et al.
Communications Medicine|January 18, 2025
Beta-variant recombinant SARS CoV-2 vaccine induces durable cross-reactive antibodies against Omicron BA variantsOdile Launay, Rachna Gupta, Tifany Machabert, et al.
BMC Infectious Diseases|September 28, 2024
Association between humoral serological markers levels and risk of SARS-CoV-2 infection after the primary COVID-19 vaccine course among ANRS0001S COV-POPART cohort participantsMathieu Chalouni, Paul Loubet, Edouard Lhomme, et al.
Infectious Diseases Now|March 17, 2024
Incidence of COVID-19 mRNA vaccine symptomatic breakthrough infections during Omicron circulation in adults with or without infection prior to vaccinationChristine Durier, Laetitia Ninove, Sylvie van der Werf, et al.
Science Translational Medicine|July 12, 2019
An IgG-induced neutrophil activation pathway contributes to human drug-induced anaphylaxisFriederike Jönsson, Luc de Chaisemartin, Vanessa Granger, et al.
Science Translational Medicine|February 15, 2013
Mucosal imprinting of vaccine-induced CD8⁺ T cells is crucial to inhibit the growth of mucosal tumorsFederico Sandoval, Magali Terme, Mevyn Nizard, et al.
Vaccine|August 23, 2025
Humoral immune response to Covid-19 vaccination in patients with cancer - Results from the ANRS0001S COV-POPART studyLiem Binh Luong Nguyen, Lyvia Magloire, Alexis François, et al.
The Lancet. Infectious Diseases|March 23, 2013
AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trialJanet E McElhaney, Jiri Beran, Jeanne-Marie Devaster, et al.
Pageof 34